Garazi Labayru

ORCID: 0000-0002-7304-320X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Neurodegenerative Diseases
  • Parkinson's Disease Mechanisms and Treatments
  • Mitochondrial Function and Pathology
  • Advanced Neuroimaging Techniques and Applications
  • Infant Development and Preterm Care
  • Functional Brain Connectivity Studies
  • Neonatal and fetal brain pathology
  • Neurology and Historical Studies
  • Neurogenetic and Muscular Disorders Research
  • Advanced MRI Techniques and Applications
  • Child and Adolescent Psychosocial and Emotional Development
  • Attention Deficit Hyperactivity Disorder
  • Alcoholism and Thiamine Deficiency
  • Cerebral Palsy and Movement Disorders
  • Hereditary Neurological Disorders
  • Microtubule and mitosis dynamics
  • Autophagy in Disease and Therapy
  • Children's Physical and Motor Development
  • Family and Disability Support Research
  • Biochemical and biochemical processes
  • Child Nutrition and Feeding Issues
  • Muscle Physiology and Disorders
  • Childhood Cancer Survivors' Quality of Life

University of the Basque Country
2018-2025

Centro de Investigación Biomédica en Red
2019-2025

Biomedical Research Networking Center on Neurodegenerative Diseases
2019-2025

Biogipuzkoa Health Research Institute
2018-2023

Instituto de Salud Carlos III
2022

Osakidetza
2020

Introduction: Myotonic dystrophy type 1 (DM1) patients show both structural and functional brain alterations, including abnormal resting-state (RS) connectivity. Although some studies have investigated RS connectivity in DM1, methodological differences make it challenging to draw consistent conclusions. Objectives: This study aims analyze 1) DM1 compared healthy controls (HC), 2) graph theory metrics, 3) longitudinal variations, 4) the relationship between clinical, cognitive, data....

10.1177/22143602241307197 article EN Journal of Neuromuscular Diseases 2025-01-01

Aging CellVolume 24, Issue 1 e14480 ADDITIONAL COVEROpen Access Additional Cover Nathalie Launay, LaunaySearch for more papers by this authorMaria Espinosa-Alcantud, Maria Espinosa-AlcantudSearch authorEdgard Verdura, Edgard VerduraSearch authorGorka Fernández-Eulate, Gorka Fernández-EulateSearch authorJon Ondaro, Jon OndaroSearch authorPablo Iruzubieta, Pablo IruzubietaSearch Marsal, MarsalSearch authorAgatha Schlüter, Agatha SchlüterSearch authorMontserrat Ruiz, Montserrat RuizSearch...

10.1111/acel.14480 article EN cc-by Aging Cell 2025-01-01

• Predominance of white matter impairment in DM1 is questioned. Age poses vulnerability to grey loss specific areas DM1. White alterations may be developmental. Muscular and genetic features are associated with brain abnormalities Neuropsychology an unspecific but strong predictor gray damage Myotonic Dystrophy type 1 (DM1) a slowly progressive myopathy characterized by varying multisystemic involvement. Several cerebral such as atrophy, ventricular enlargement, lesions (WMLs) have...

10.1016/j.nicl.2019.102078 article EN cc-by-nc-nd NeuroImage Clinical 2019-01-01

Myotonic Dystrophy Type 1 (DM1) is a multisystemic disease that affects gray and white matter (WM) tissues. WM changes in DM1 include increased hyperintensities altered tract integrity distributed widespread manner. However, the precise temporal spatial progression of are yet undetermined. MRI data were acquired from 8 adult- late-onset patients 10 healthy controls (HC) at two different timepoints over 9.06 years. Fractional anisotropy (FA) mean diffusivity (MD) variations assessed with...

10.1038/s41598-022-07820-1 article EN cc-by Scientific Reports 2022-03-07

Myotonic dystrophy type 1 (DM1) is an inherited multi-systemic disease involving the central nervous system (CNS) and consequently characterized by a range of cognitive impairments. However, whether this profile progresses over time still matter debate. The aim study was to longitudinally assess DM1 sample, in order compare, for first time, progression with that control group. Clinical socio-demographic predictive factors potentially implicated possible decline are analysed.Seventy-five...

10.1111/jnp.12192 article EN cc-by-nc-nd Journal of Neuropsychology 2019-08-13

Abstract Objective To characterize the progression of brain structural abnormalities in adults with pediatric and adult/late onset DM1, as well to examine potential predictive markers such progression. Methods 21 DM1 patients (pediatric onset: N = 9; 12) 18 healthy controls (HC) were assessed longitudinally over 9.17 years through MRI. Additionally, underwent neuropsychological, genetic, muscular impairment assessment. Inter‐group comparisons total voxel‐level regional volume conducted Voxel...

10.1002/acn3.51163 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2020-09-02

Introduction Myotonic dystrophy type 1 (DM1) is a hereditary neuromuscular disorder affecting the central nervous system (CNS). Although sex differences have been explored in other disorders, research on this topic DM1 remains limited. The present study aims to analyze (both patient’s and disease-transmitting parent’s sex) with focus CNS outcomes. Methods Retrospective data from 146 non-congenital patients were analyzed, including clinical, molecular, neuropsychological, neuroradiological...

10.3389/fneur.2024.1399898 article EN cc-by Frontiers in Neurology 2024-05-09

Aims The cognitive profile of Myotonic Dystrophy type 1 (DM1) has been described in recent decades. Moreover, DM1 patients show lowered social engagement and difficulties social-cognitive functions. aim the present study is to explore whether cognition impairment taking into account overall condition. Method 38 a control group paired age gender participated study. All participants had an IQ within normal range. Subjects were administered abbreviated neuropsychological battery which comprised...

10.1371/journal.pone.0204227 article EN cc-by PLoS ONE 2018-09-24

Central nervous system dysfunction is characteristic of patients with myotonic dystrophy type 1 (DM1). Although no consensus exists regarding the exact cognitive profile these patients, executive has been suggested to play a role. Due impact functions on daily performance, this study aimed describe functioning in an ecological manner and analyze its - that other clinical variables functional performance DM1 patients. A Virtual Reality test (Nesplora Ice Cream), Wechsler Adult Intelligence...

10.1016/j.nmd.2023.10.006 article EN cc-by-nc-nd Neuromuscular Disorders 2023-10-18

Determine whether SGA constitutes a neurodevelopmental risk-factor of MLP, exploring if potential developmental difficulties at toddlerhood persist and are related to school-age performance. 109 adequate for gestational age MLP children were evaluated 2 6.5 y.o. obtained poorer results in several areas both timepoints; their development strongly correlated with only some school-age. confers vulnerability evolving from global/unspecific domain-specific profile (attentional/dysexecutive) 6.5....

10.1080/87565641.2021.1939349 article EN cc-by-nc-nd Developmental Neuropsychology 2021-05-19

Currently, no rapid and specific instrument is available to briefly estimate intelligence in patients with myotonic dystrophy type 1 (DM1), a multisystemic disease that involves the CNS associated cognitive deficits low intellectual functioning. This study aimed develop DM1-specific valid short-form of Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) functioning this population. Thirty non-congenital DM1 (10 female; mean age=46.77; SD= 9.76) were assessed WAIS-IV. Data analyzed...

10.1016/j.nmd.2022.06.012 article EN cc-by-nc-nd Neuromuscular Disorders 2022-07-04

Abstract Senescence, marked by permanent cell cycle arrest may contribute to the decline in regenerative potential and neuronal function, thereby promoting neurodegenerative disorders. In this study, we employed whole exome sequencing identify a previously unreported biallelic missense variant SVBP (p.Leu49Pro) six patients from three unrelated families. These affected individuals present with complex hereditary spastic paraplegia (HSP), peripheral neuropathy, verbal apraxia, intellectual...

10.1111/acel.14355 article EN cc-by Aging Cell 2024-10-16

Myotonic dystrophy type 1 (DM1) is a hereditary and multisystemic disease that characterized by heterogeneous manifestations. Although muscular impairment central to DM1, premanifest DM1 form has been proposed for those the absence of muscle signs in precursory phases. Nevertheless, subtle and/or symptoms related other systems, such as nervous system (CNS), may emerge progress gradually. This study aimed validate concept characterize track affected individuals from CNS centred...

10.1111/ene.15604 article EN cc-by-nc-nd European Journal of Neurology 2022-10-18

Abstract Despite significant research, the biological mechanisms underlying brain degeneration in Myotonic Dystrophy Type I (DM1) remain largely unknown. Here we have assessed by measuring volume loss (VL) and cognitive deficits (CD) two cohorts of DM1 patients, associating them to large-scale transcriptome maps provided Allen Human Brain Atlas (AHBA). From a list preselected hypothesis-driven genes, three appear play major role degeneration: dystrophin ( DMD) , alpha-synuclein SNCA)...

10.1101/2020.07.17.208132 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-07-17

Very preterm children (gestational age < 32 weeks) frequently show neurodevelopmental difficulties (Inattention/dysexecutiveness) throughout their life-stages. A scarcity of resources, along with this population’s cognitive vulnerability, makes the neuropsychological evaluation these both complicated and time-consuming. This study aimed to develop a specific valid Wechsler Intelligence Scale for Children-Fifth Edition (WISC-V) short-form estimate intellectual functioning in...

10.3389/fpsyg.2021.789124 article EN cc-by Frontiers in Psychology 2021-12-17

Introduction Among the cognitive difficulties shown by myotonic dystrophy type 1 (DM1) patients, visuoconstructional impairment – specifically measured with Rey-Osterrieth Complex Figure Test (RCFT) is particularly notable. This study aimed to analyze performance of DM1 patients and healthy controls (HC) in RCFT, using different correction systems order explore processes underlying poor its associations other signs symptoms.

10.1080/13803395.2023.2274623 article EN cc-by-nc-nd Journal of Clinical and Experimental Neuropsychology 2023-11-07

Abstract Background: Myotonic Dystrophy Type 1 (DM1) is a multisystemic disease that affects gray and white matter (WM) tissues. WM changes in DM1 include increased hyperintensities altered tract integrity distributed widespread manner. However, the precise spatiotemporal are yet undetermined. Methods: MRI data were acquired from 8 adult- late-onset patients 10 healthy controls (HC) at two different timepoints over 9.06 years. Fractional anisotropy (FA) variations assessed with Tract-Based...

10.21203/rs.3.rs-737338/v1 preprint EN cc-by Research Square (Research Square) 2021-07-23
Coming Soon ...